202 related articles for article (PubMed ID: 32871611)
1. Internalisation and toxicity of amyloid-β 1-42 are influenced by its conformation and assembly state rather than size.
Vadukul DM; Maina M; Franklin H; Nardecchia A; Serpell LC; Marshall KE
FEBS Lett; 2020 Nov; 594(21):3490-3503. PubMed ID: 32871611
[TBL] [Abstract][Full Text] [Related]
2. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
[TBL] [Abstract][Full Text] [Related]
3. The Co-oligomers of Aβ42 and Human Islet Amyloid Polypeptide Exacerbate Neurotoxicity and Alzheimer-like Pathology at Cellular Level.
Deng J; Liu B; Tao Q; Luo Y; Zhu Y; Huang X; Yue F
Neuroscience; 2024 May; 547():37-55. PubMed ID: 38604526
[TBL] [Abstract][Full Text] [Related]
4. Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.
Cohen SI; Linse S; Luheshi LM; Hellstrand E; White DA; Rajah L; Otzen DE; Vendruscolo M; Dobson CM; Knowles TP
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9758-63. PubMed ID: 23703910
[TBL] [Abstract][Full Text] [Related]
5. α-synuclein-assisted oligomerization of β-amyloid (1-42).
Chau E; Kim JR
Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
[TBL] [Abstract][Full Text] [Related]
6. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.
Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y
J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899
[TBL] [Abstract][Full Text] [Related]
7. C-terminal peptides coassemble into Abeta42 oligomers and protect neurons against Abeta42-induced neurotoxicity.
Fradinger EA; Monien BH; Urbanc B; Lomakin A; Tan M; Li H; Spring SM; Condron MM; Cruz L; Xie CW; Benedek GB; Bitan G
Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14175-80. PubMed ID: 18779585
[TBL] [Abstract][Full Text] [Related]
8. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
Ferrera D; Mazzaro N; Canale C; Gasparini L
Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein.
Miyamae Y; Kurisu M; Murakami K; Han J; Isoda H; Irie K; Shigemori H
Bioorg Med Chem; 2012 Oct; 20(19):5844-9. PubMed ID: 22921742
[TBL] [Abstract][Full Text] [Related]
10. Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species.
Jan A; Adolfsson O; Allaman I; Buccarello AL; Magistretti PJ; Pfeifer A; Muhs A; Lashuel HA
J Biol Chem; 2011 Mar; 286(10):8585-8596. PubMed ID: 21156804
[TBL] [Abstract][Full Text] [Related]
11. Amyloid β cytotoxicity is enhanced or reduced depending on formation of amyloid β oligomeric forms.
Shahnawaz M; Bilkis T; Park IS
Biotechnol Lett; 2021 Jan; 43(1):165-175. PubMed ID: 33025333
[TBL] [Abstract][Full Text] [Related]
12. NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril.
Xiao Y; Matsuda I; Inoue M; Sasahara T; Hoshi M; Ishii Y
J Biol Chem; 2020 Jan; 295(2):458-467. PubMed ID: 31771980
[TBL] [Abstract][Full Text] [Related]
13. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
[TBL] [Abstract][Full Text] [Related]
14. Curcumin Dictates Divergent Fates for the Central Salt Bridges in Amyloid-β
Chandra B; Mithu VS; Bhowmik D; Das AK; Sahoo B; Maiti S; Madhu PK
Biophys J; 2017 Apr; 112(8):1597-1608. PubMed ID: 28445751
[TBL] [Abstract][Full Text] [Related]
15. Toxicity in rat primary neurons through the cellular oxidative stress induced by the turn formation at positions 22 and 23 of Aβ42.
Izuo N; Kume T; Sato M; Murakami K; Irie K; Izumi Y; Akaike A
ACS Chem Neurosci; 2012 Sep; 3(9):674-81. PubMed ID: 23019494
[TBL] [Abstract][Full Text] [Related]
16. Synthetic Models of Quasi-Stable Amyloid β40 Oligomers with Significant Neurotoxicity.
Irie Y; Murakami K; Hanaki M; Hanaki Y; Suzuki T; Monobe Y; Takai T; Akagi KI; Kawase T; Hirose K; Irie K
ACS Chem Neurosci; 2017 Apr; 8(4):807-816. PubMed ID: 28026168
[TBL] [Abstract][Full Text] [Related]
17. Preparation and Fractionation of Heterogeneous Aβ42 Oligomers with Different Aggregation Properties.
Chen EW; Guo Z
Methods Mol Biol; 2023; 2551():29-39. PubMed ID: 36310194
[TBL] [Abstract][Full Text] [Related]
18. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates.
Sharoar MG; Thapa A; Shahnawaz M; Ramasamy VS; Woo ER; Shin SY; Park IS
J Biomed Sci; 2012 Dec; 19(1):104. PubMed ID: 23259691
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
[TBL] [Abstract][Full Text] [Related]
20. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.
Kaneko I; Morimoto K; Kubo T
Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
